Data Science in the News

Livermore WiDS provides forum for women in data science

March 18, 2022- 
LLNL celebrated the 2022 Global Women in Data Science (WiDS) conference on March 7 with its fifth annual regional event, featuring workshops, mentoring sessions and a discussion with LLNL Director Kim Budil, the first woman to hold that role. For the second straight year, the WiDS Livermore event was entirely virtual due to the COVID-19 pandemic. Attendees tuned in to view talks and...

Machine learning model finds COVID-19 risks for cancer patients

March 10, 2022- 
A new study by researchers at LLNL and the University of California, San Francisco, looks to identify cancer-related risks for poor outcomes from COVID-19. Analyzing one of the largest databases of patients with cancer and COVID-19, the team found previously unreported links between a rare type of cancer—as well as two cancer treatment-related drugs—and an increased risk of hospitalization...

Winter hackathon meets WiDS datathon

March 9, 2022- 
Sponsored by the DSI, LLNL’s winter hackathon took place on February 16–17. Hackathons are 24-hour events that encourage collaborative programming and creative problem solving. In addition to traditional hacking, the hackathon included a special datathon competition in anticipation of the Women in Data Science (WiDS) conference on March 7. Hackathon and datathon participants presented their...

LLNL team models COVID-19 disease progression and identifies risk factors

Feb. 15, 2022- 
An LLNL team has developed a comprehensive dynamic model of COVID-19 disease progression in hospitalized patients, finding that risk factors for complications from the disease are dependent on the patient’s disease state. Using a machine learning algorithm on a dataset of electronic health records from more than 1,300 hospitalized COVID-19 patients with ProMedica — the largest health care...

WiDS Livermore returns on March 7

Feb. 10, 2022- 
We are hosting our 5th WiDS Livermore regional event to encourage our community of women in computing. We will watch the WiDS Stanford Livestream as well as feature Lab-focused technical talks, mentoring breakout sessions, and a career panel. WiDS Livermore is an independent event hosted by LLNL Ambassadors as part of the annual Women in Data Science (WiDS) Worldwide conference organized...

LLNL joins Human Vaccines Project to accelerate vaccine development and understanding of immune response

Oct. 21, 2021- 
LLNL has joined the international Human Vaccines Project (HVP), bringing Lab expertise and computing resources to the consortium to aid development of a universal coronavirus vaccine and improve understanding of immune response. The HVP is a nonprofit, public-private partnership with a mission to decode the human immune system and accelerate the development of vaccines and immunotherapies...

Tackling the COVID-19 pandemic

Oct. 11, 2021- 
To help the U.S. fight the COVID-19 pandemic, LLNL did what it does best: quickly bring together interdisciplinary teams and diverse technologies to address urgent national challenges. This effort includes applying advanced high-performance computing resources to biological research and anayzing complicated computer models and enormous datasets. Read more in Science & Technology Review.

Career panel series kicks off with women in Computing leadership roles

July 6, 2021- 
More than 100 LLNL staff and students gathered virtually for the first session of a new career panel series inspired by the annual WiDS conference and sponsored by the DSI. Panelists discussed how they have shaped their careers at the Lab and in Computing, their journeys into leadership roles, and how they navigate career challenges. Data scientist and panel series organizer Cindy Gonzales...

COVID-19 detection and analysis with Nisha Mulakken (VIDEO)

June 7, 2021- 
LLNL biostatistician Nisha Mulakken has enhanced the Lawrence Livermore Microbial Detection Array (LLMDA) system with detection capability for all variants of SARS-CoV-2. The technology detects a broad range of organisms—viruses, bacteria, archaea, protozoa, and fungi—and has demonstrated novel species identification for human health, animal health, biodefense, and environmental sampling...

Laser-driven ion acceleration with deep learning

May 25, 2021- 
While advances in machine learning over the past decade have made significant impacts in applications such as image classification, natural language processing and pattern recognition, scientific endeavors have only just begun to leverage this technology. This is most notable in processing large quantities of data from experiments. Research conducted at LLNL is the first to apply neural...

The data-driven future of extreme physics

May 19, 2021- 
By applying modern machine learning and data science methods to “extreme” plasma physics, researchers can gain insight into our universe and find clues about creating a limitless amount of energy. In a recent perspective published in Nature, LLNL scientists and international collaborators outline key challenges and future directions in using machine learning and other data-driven techniques...

COVID-19 HPC Consortium reflects on past year

April 1, 2021- 
COVID-19 HPC Consortium scientists and stakeholders met virtually on March 23 to mark the consortium’s one-year anniversary, discussing the progress of research projects and the need to pursue a broader organization to mobilize supercomputing access for future crises. The White House announced the launch of the public-private consortium, which provides COVID-19 researchers with free access to...

Lab event encourages growth of women in data science

March 17, 2021- 
Coinciding with International Women’s Day on March 8, LLNL’s 4th Women in Data Science (WiDS) regional event brought women together to discuss successes, opportunities and challenges of being female in a mostly male field. The Lab’s first-ever virtual WiDS gathering attracted dozens of LLNL data scientists as well as some from outside the Lab, and featured speakers, a career panel and...

Model for COVID-19 drug discovery a Gordon Bell finalist

Nov. 17, 2020- 
A machine learning model developed by a team of LLNL scientists to aid in COVID-19 drug discovery efforts is a finalist for the Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research. Using Sierra, the world’s third fastest supercomputer, LLNL scientists produced a more accurate and efficient generative model to enable COVID-19 researchers to produce novel compounds...

DOE announces five new energy projects at LLNL

Nov. 13, 2020- 
The DOE today announced two rounds of awards for the High Performance Computing for Energy Innovation Program HPC4EI), including five projects at LLNL. HPC4EI connects industry with the computational resources and expertise of the DOE national laboratories to solve challenges in manufacturing, accelerate discovery and adoption of new materials and improve energy efficiency. The awards were...

Advancing healthcare with data science (VIDEO)

Aug. 3, 2020- 
This video provides an overview of projects in which data scientists work with domain scientists to address major challenges in healthcare. To help fight the COVID-19 pandemic, researchers are developing computer models to search for potential antibody and antiviral drug treatments, sharing a data portal with scientists and the general public, and analyzing drug compounds via a novel text...

COVID-19 research goes public through new portal

May 18, 2020- 
A new online data portal is making available to the public a wealth of data LLNL scientists have gathered from their ongoing COVID-19 molecular design projects, particularly the computer-based “virtual” screening of small molecules and designed antibodies for interactions with the SARS-CoV-2 virus for drug design purposes. The portal houses a wealth of data LLNL scientists have gathered from...

New ML platform generates novel COVID-19 antibody sequences for experimental testing

May 1, 2020- 
LLNL researchers have identified an initial set of therapeutic antibody sequences, designed in a few weeks using machine learning and supercomputing, aimed at binding and neutralizing SARS-CoV-2, the virus that causes COVID-19. The research team is performing experimental testing on the chosen antibody designs. Read more at LLNL News.

Upgrades for LLNL supercomputer from AMD, Penguin Computing aid COVID-19 research

April 21, 2020- 
Under a new agreement, AMD will supply upgraded graphics accelerators for LLNL’s Corona supercomputing cluster, expected to nearly double the system’s peak compute power. The system will be used by scientists through the public/private COVID-19 HPC Consortium, and by LLNL researchers, who are working on discovering potential antibodies and anti-viral compounds for SARS-CoV-2, the virus that...

Lab promotes diversity, tech at Women in Data Science regional event

April 3, 2020- 
For the third consecutive year, Lawrence Livermore National Laboratory (LLNL) hosted a Women in Data Science (WiDS) regional event on March 2. Held at the HPC Innovation Center, the event drew dozens of attendees from LLNL, Sandia National Laboratories, local universities, and Bay Area commercial companies. Livermore was one of over 200 regional events in 60 countries coordinated with the...